Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy

Min Li,Shuya Li,Han Zhou,Xinfeng Tang,Yi Wu,Wei Jiang,Zhigang Tian,Xuechang Zhou,Xianzhu Yang,Yucai Wang
DOI: https://doi.org/10.1038/s41467-020-14963-0
IF: 16.6
2020-02-28
Nature Communications
Abstract:Abstract The efficacy of nano-mediated drug delivery has been impeded by multiple biological barriers such as the mononuclear phagocyte system (MPS), as well as vascular and interstitial barriers. To overcome the abovementioned obstacles, we report a nano-pathogenoid (NPN) system that can in situ hitchhike circulating neutrophils and supplement photothermal therapy (PTT). Cloaked with bacteria-secreted outer membrane vesicles inheriting pathogen-associated molecular patterns of native bacteria, NPNs are effectively recognized and internalized by neutrophils. The neutrophils migrate towards inflamed tumors, extravasate across the blood vessels, and penetrate through the tumors. Then NPNs are rapidly released from neutrophils in response to inflammatory stimuli and subsequently taken up by tumor cells to exert anticancer effects. Strikingly, due to the excellent targeting efficacy, cisplatin-loaded NPNs combined with PTT completely eradicate tumors in all treated mice. Such a nano-platform represents an efficient and generalizable strategy towards in situ cell hitchhiking as well as enhanced tumor targeted delivery.
multidisciplinary sciences
What problem does this paper attempt to address?
This paper attempts to solve the problems of multiple biological barriers encountered by nanoparticles (NPs) in tumor treatment, which hinder the effectiveness of nano - mediated drug delivery. Specifically, nanoparticles are easily and rapidly cleared by the mononuclear phagocyte system (MPS), and it is difficult for them to penetrate the vascular and tumor interstitial barriers. To solve these problems, the authors proposed a new type of nano - pathogenoids (NPNs) system, aiming to improve the efficiency of tumor - targeted delivery in the following ways: 1. **Utilizing chemotaxis - driven neutrophil delivery**: NPNs can "hitchhike" neutrophils in the blood circulation. These neutrophils will migrate to the inflamed tumor site, cross the blood vessels and infiltrate into the tumor tissue. 2. **Combining with photothermal therapy (PTT)**: PTT can induce a local acute inflammatory environment, thereby recruiting more neutrophils and further enhancing the delivery effect of NPNs. 3. **Improving the anti - cancer effect**: The experimental results show that cisplatin - loaded NPNs combined with PTT can completely eradicate tumors in all treated mice. ### Core issues of the paper - **How to overcome the biological barriers encountered by nanoparticles during in - vivo delivery?** - **How to utilize the chemotactic properties of neutrophils to improve the tumor - targeted delivery of nano - drugs?** - **How to enhance the therapeutic effect of nano - drugs by combining with photothermal therapy?** ### Solutions The authors designed nanoparticles (NPNs) coated with outer membrane vesicles (OMVs) of bacteria, enabling these nanoparticles to be recognized and endocytosed by neutrophils. NPNs inherit the pathogen - associated molecular patterns (PAMPs) of natural bacteria, so they can be effectively recognized and transported by neutrophils. In addition, the local inflammatory environment induced by PTT further promotes the recruitment of neutrophils, enabling NPNs to reach the tumor site more efficiently and exert their anti - cancer effects. ### Experimental verification - **Recruitment of neutrophils**: After PTT treatment, the number of neutrophils at the tumor site increased significantly. - **Delivery efficiency of NPNs**: Compared with ordinary nanoparticles, the accumulation of NPNs at the tumor site increased significantly. - **Therapeutic effect**: The combination of NPNs and PTT can completely eradicate tumors in mice. Through these experimental results, the authors have proven that NPNs, as an efficient nano - platform, have great potential in overcoming biological barriers and improving tumor - targeted delivery.